HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga Meiri Chaim Selected Research

Spider Bites (Spider Bite)

1/2017Highlights in the knowledge of brown spider toxins.
1/2017Potential Implications for Designing Drugs Against the Brown Spider Venom Phospholipase-D.
12/2015Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
6/2014Recent advances in the understanding of brown spider venoms: From the biology of spiders to the molecular mechanisms of toxins.
12/2013Differential metalloprotease content and activity of three Loxosceles spider venoms revealed using two-dimensional electrophoresis approaches.
11/2013Brown spider phospholipase-D containing a conservative mutation (D233E) in the catalytic site: identification and functional characterization.
6/2013Modulation of membrane phospholipids, the cytosolic calcium influx and cell proliferation following treatment of B16-F10 cells with recombinant phospholipase-D from Loxosceles intermedia (brown spider) venom.
5/2009Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
11/2008Effects of the venom and the dermonecrotic toxin LiRecDT1 of Loxosceles intermedia in the rat liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga Meiri Chaim Research Topics

Disease

9Spider Bites (Spider Bite)
01/2017 - 11/2008
4Hemolysis
06/2014 - 06/2011
2Renal Insufficiency (Renal Failure)
06/2014 - 11/2013
2Erythema
11/2013 - 09/2006
2Edema (Dropsy)
05/2009 - 04/2009
2Bites and Stings (Sting)
05/2009 - 02/2006
1Glioblastoma (Glioblastoma Multiforme)
10/2018
1Neoplasms (Cancer)
10/2018
1Thrombocytopenia (Thrombopenia)
06/2014
1Ecchymosis
05/2009
1Necrosis
05/2009
1Thrombosis (Thrombus)
06/2006
1Blister (Bulla)
06/2006
1Acute Kidney Injury (Acute Renal Failure)
02/2006
1Hematuria
02/2006
1Fever (Fevers)
02/2006
1Disseminated Intravascular Coagulation
02/2006
1Vomiting
02/2006
1Hemolytic Anemia
02/2006
1Azotemia
02/2006

Drug/Important Bio-Agent (IBA)

7VenomsIBA
06/2014 - 02/2006
4Phospholipase DIBA
01/2017 - 06/2013
4loxosceles venomIBA
12/2015 - 11/2013
2Spider Venoms (Venom, Spider)IBA
01/2017 - 06/2014
2Protein Isoforms (Isoforms)IBA
01/2017 - 04/2009
1Transcription Factors (Transcription Factor)IBA
10/2018
1myocardinIBA
10/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2018
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1hyaluronate lyase (spreading factor)IBA
01/2017
1Biological ProductsIBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2017
1astacinIBA
12/2013
1Peptide Hydrolases (Proteases)FDA Link
12/2013
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2013
1Complement System Proteins (Complement)IBA
11/2013
1LipidsIBA
11/2013
1Phospholipases (Phospholipase)IBA
06/2011
1Fibrinogen (Factor I)FDA Link
05/2009
1Antivenins (Antivenoms)IBA
05/2009
1Histamine (Histamine Dihydrochloride)FDA Link
04/2009
1Methysergide (Sansert)FDA Link
04/2009
1Cetirizine (Zyrtec)FDA LinkGeneric
04/2009
1Serotonin (5 Hydroxytryptamine)IBA
04/2009
1Transaminases (Aminotransferases)IBA
11/2008
1FibrinIBA
06/2006
1Urea (Carbamide)FDA LinkGeneric
02/2006
1NitrogenIBA
02/2006

Therapy/Procedure

2Therapeutics
06/2014 - 05/2009
1Intradermal Injections
09/2006